CYCC - Premarket Gainers as of 9:05 am (09/05/2018) September, 05 2018 09:21 AM Cyclacel Pharmaceuticals Inc. PRQR +66% on positive interim results from Phase 1/2 clinical trial of QR-110 in LCA10 patients. More news on: ProQR Therapeutics, Cronos Group, Inc., Nevsun Resources Ltd., Stocks on the move, , Read more ...